---
title: 'DDG 2025 Research: Presentation by Michael Roden, MD'
description: >-
  Read the latest news on regulatory-grade real-world evidence: DDG 2025
  Research: Presentation by Michael Roden, MD.
date: '2025-06-09'
category: News
tags:
  - Conference Presentation
  - R&D
  - Care
  - Cross-cutting
  - General
canonical_url: >-
  https://www.pedestalhealth.com/resources/news/conference-presentation/ddg-2025-research-presentation-by-michael-roden-md/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: ddg-2025-research-presentation-by-michael-roden-md
id: 2ds6ADS4xll1W5XqtzCbQS
contentType: article
---

Target RWE is proud to feature a significant new study presented at DDG 2025 by our esteemed MASH Steering Committee member, **Dr. Michael Roden**. Titled "Relationship between liver biopsy fibrosis stage and clinical outcomes among persons with MASLD/MASH in a real-world setting," this research delves into the critical impact of liver biopsy fibrosis stage and its dynamic changes over time on severe clinical outcomes in MASLD/MASH patients.

Utilizing robust real-world data, this study offers invaluable insights into how disease progresses outside of controlled clinical trial environments, providing a deeper understanding of patient journeys and the long-term implications of fibrosis. View Dr. Roden's compelling video presentation to explore these findings further.